Latest News and Press Releases
Want to stay updated on the latest news?
-
LOS ALTOS, Calif. and LOS ANGELES, July 09, 2018 (GLOBE NEWSWIRE) -- Retrotope and collaborators led by Dr. Marie-Francoise Chesselet, the Charles H. Markham Professor of Neurology, and Interim...
-
Patient enrollment anticipated to start in July 2018 LOS ALTOS, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Retrotope announced today that the U.S. Food and Drug Administration (FDA) has granted the...
-
LOS ALTOS, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- Retrotope announced today the start of two single-patient, Compassionate Use trials of RT001 at major university medical centers in Late Onset...
-
Positive Findings from Compassionate Use Study in Patient with Infantile Neuroaxonal Dystrophy (INAD) Presented LOS ALTOS, Calif., April 24, 2018 (GLOBE NEWSWIRE) -- Retrotope announced today...
-
Protocol for Pivotal Clinical Trial Has Been Submitted to the US FDA LOS ALTOS, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- Retrotope announced today peer-reviewed publication of positive Phase...
-
LOS ALTOS, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Retrotope announced today that the U.S. Food and Drug Administration’s (FDA’s) Office of Orphan Products Development (OOPD) granted orphan drug...
-
LOS ALTOS, Calif. and TORONTO, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Retrotope and collaborators, led by Dr. Brian Bennett of Queen’s University, have published a paper entitled “Deuterium-reinforced...